IP Programs: Bridging the Gap you are not alone Neil Pascoe RN BSN CIC Epidemiologist Emerging and Infectious Disease Branch Infectious Disease Control.

Slides:



Advertisements
Similar presentations
East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.
Advertisements

Infection Control in CKD A Culture of Safety Leona Dinnan, RN, CDN.
ACT 52 - Healthcare-Associated Infections
Development of Healthcare- Associated Infections: Role of the Built Environment James P. Steinberg, MD Division of Infectious Diseases Emory University.
James Marx, PhD, RN, CIC Broad Street Solutions October 2014.
Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC.
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
Clostridium difficile infections (CDI) surveillance in Colorado Kelly R. Kast, MSPH.
Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal
Isolation Precaution Signage in Washington State
2013 CLOSTRIDIUM DIFFICILE EDUCATIONAL AND CONSENSUS CONFERENCE March 11-12, 2013.
Collaborative to Reduce Healthcare Associated Infections
Agenda Regulatory/Department Updates Compliance Trend Report Compliance Tips: Deborah Cateora Hot Topics: Manager’s Corner: Cory Oace.
CDC Winnable Battles: Preventing Healthcare-Associated Infections (HAIs) National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
Preventing Transmission of MRSA in the Hospital Setting Patricia A. Pearson RN, CIC Infection Prevention & Control Synergy / St. Joseph’s Hospital.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
Healthcare-associated Infections and Antibiotic Resistance
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
Objectives After this session, the attendee should be able to:
Antibiotic overuse and misuse in long term care Shira Doron, MD Assistant Professor of Medicine Division of Geographic Medicine and Infectious Diseases.
Preventing Multidrug-Resistant Organisms (MDROs) What the Direct Caregiver Should Know Prepared by: Ann Bailey, RNC, BSN, CIC Joanne Dixon, RN, MN, CIC.
MRSA in Corrections Danae Bixler, MD, MPH
Infection Control- Issues in the Community Dr Yimmy Chow Interim Director and Consultant in Communicable Disease Control NW London Health Protection Team,
Robynn Cheng Leidig, MPH
Laura Strohmeyer RN, CGRN, CASC AmSurg Corp Dallas, Texas Texas ASCS 2013 Annual Meeting.
Getting Started or so you are the new Infection Preventionist – what now? Karen Hoover Russ Olmsted Ruth Anne Rye.
Alice Guh, MD, MPH Division of Healthcare Quality Promotion Centers for Disease Control and Prevention CSTE CRE Panel Session – June 14, 2011 Public Health.
DIVISION OF LICENSING & CERTIFICATION, BUREAU OF HEALTH SYSTEMS (BHS) - MDCH (517) Fax (517)
Methicillin-resistant Staphylococcus Aureus - MRSA - Sharon Walker, RN, BPS Ingham County Health Department.
Long Term Care CDI/MDRO Prevention Collaborative: Connecticut Program Update Richard Melchreit, MD HAI Program Coordinator.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
Shira Doron, MD Assistant Professor of Medicine
Antimicrobial Stewardship
Healthcare Delivery System
Preventing Transmission of C. difficile: Practice Elise Tamplin, M(ASCP), MPH, CIC Brigham & Women’s Hospital.
Preventing and Treating C.difficile Lisa Casey, M.D. Assistant Professor, UT Southwestern Medical Center TSGE / SGNA Annual Scientific Meeting September.
CDI Prevention in Long Term Care Collaborative Welcome and Project Overview Deborah Quetti RN, MBA, BSN, CPHQ April 9, 2014.
© Aurora Health Care, Inc. Carbapenem Resistant Enterobacteriaceae The Alphabet Soup of Infection Prevention Aurora Health Care System Infection Prevention.
Moving forward together infection prevention and control and AMR Rose Gallagher Nurse Advisor Infection Prevention and Control Royal College of Nursing.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
LARGEST & FASTEST GROWING INDUSTRY. HOSPITALS Acute care facility Focus on critical needs of patient Average length of stay 4.8 days Classified by type.
Time To Regain Control Management of Multi-Drug Resistant Organisms in Healthcare Settings
Health Care Associated Infections Advisory Panel (HAI) Update Infectious Disease Epidemiology Workgroup June 27, 2008 Austin, Texas Wes Hodgson, MPA Infectious.
Carbapenemase- Producing Carbapenem-Resistant Enterobacteriaceae Nicole Hearon, HAI Epidemiologist Surveillance and Investigation Division Indiana State.
Healthcare Delivery System Foundation Standard Understand the healthcare delivery system (public, private, government and non-profit)
Getting Started or so you are the new Infection Preventionist – what now? Karen Hoover Russ Olmsted Ruth Anne Rye.
Outlines At the completion of this lecture the student will be able to identify the concept and related terms of: Infection- Infection control-
Patient Protection and Affordable Care Act The Greens: Elijah, Amber, Kayla, Patrick.
Health Care Systems Delivering Health Care to the Community.
Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.
U.S. Strategies to Improve Human Antibiotic Use Lauri A. Hicks, D.O. Director, Office of Antibiotic Stewardship April 13, 2016 National Center for Emerging.
KJO Hospital Infection Control Local 2176/2097 Ross Ibabao/ICCo.
Epidemiology of Hospital Acquired Infections By Alena Bosconi, Candice Smith, Dusica Goralewski SUNY Delhi Biol , Infection and Disease Dr. Marsha.
CDC Winnable Battles: Preventing Healthcare-Associated Infections (HAIs) National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
The What and Why of Antimicrobial Stewardship Kelly Kauber, MPH Antimicrobial Stewardship in LTC, May 12th, 2016.
Infection Prevention Foundations For Long Term Care Jamie Moran, MSN, RN, CIC Quality Improvement Consultant May 12, 2016.
Part III Key Strategies for Combating Resistance.
Jean B. Patel, PhD, D(ABMM) Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Disease Centers for Disease Control.
Yousef I. Aljeesh, PhD, RN Said Abusalem, PhD, RN Naeem Alkariri, MSN, RN John A. Myers, PhD, MSPH Fawwaz Alaloul, PhD, RN Staff Developed IP Program Increases.
The Illinois Clostridium difficile Prevention Collaborative.
Partnerships to Prevent Healthcare Associated Infections and Antibiotic Resistance: Challenges and Opportunities Nimalie D. Stone, MD Medical Officer Prevention.
Partnerships to Prevent Healthcare Associated Infections and Antibiotic Resistance: Challenges and Opportunities Nimalie D. Stone, MD Medical Officer Prevention.
Kelley Garner, MPH MLS(ASCP)CM
Introduction to Antimicrobial Resistance
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
Chapter 1: Introduction to Multidrug – Resistant Organisms
Hospital Antibiotic Stewardship Programs
Department of Aging and Disability Services
National Center for Emerging and Zoonotic Infectious Diseases
Legislative & Regulatory Updates
Presentation transcript:

IP Programs: Bridging the Gap you are not alone Neil Pascoe RN BSN CIC Epidemiologist Emerging and Infectious Disease Branch Infectious Disease Control Unit IIPW DFW APIC 10/24/13

Today’s Objectives Compare regulatory requirements, standard of care, residents’ rights, oversight, and funding for different practice settings. Discuss the identification of infectious disease, reporting requirements, and infection prevention and control measures. Discuss the issues associated with the transfer of patients among facilities.

(

DSHS Regulates Abortion Facilities Ambulatory Surgical Centers Birthing Centers Community Mental Health Centers Comprehensive Out-Patient Rehabilitation Facilities End Stage Renal Disease Facilities Freestanding Emergency Medical Care Facilities Hospitals - General Hospitals - Psychiatric & Crisis Stabilization Units Hospitals - Special Laboratories - (CLIA) Narcotic Treatment Clinics Out-Patient Physical Therapy or Speech Pathology Services Portable X-Ray Services Rural Health Clinics Special Care Facilities Substance Abuse

DADS Regulates one Adult Foster Care Assisted Living Facilities Home and Community-based Services Primary Home Care Hospice Intermediate Care Facilities Nursing Homes Residential Care State Supported Living Centers

DADS Regulates two Area agencies on aging Area agencies on aging transportation Community Attendant Services Community Based Alternatives Community Living Assistance and Support Services Consumer Directed Services Consumer Managed Personal Assistance Services Day Activity and Health Services Deaf Blind with Multiple Disabilities Emergency Response Services Family Care Guardianship Program Home Delivered Meals In-Home and Family Support Local authorities Medically Dependent Children Program Pre-admission Screening and Resident Review Program of All-Inclusive Care for the Elderly Promoting Independence Special Services to Persons with Disabilities Special Services to Persons with Disabilities 24-Hour Shared Attendant Care Texas Home Living

Similarities between DSHS and DADS Both license multiple facility types Both have a regulatory function Both receive state and federal funds to operate Both advocate for healthy Texans

Resident’s Rights People moving into a LTCF become “residents” Resident’s receiving care in a LTC facility are essentially at home

DADS IC Regulatory Enforcement Federal 42 CFR § (F441) – Combines F441, 442, 443, 444 and 445 State 40 TAC Part 1 Chapter 19 subchapter Q – addresses IC requirements Both require facilities to establish and maintain an IC program designed to provide a safe, sanitary, and comfortable environment to prevent the introduction and transmission of disease

Provider Letters SHEA/APIC Recommendations for IC in LTCF vaccines for residents vaccines for HCW DADS TRAINING ng/jointtraining.cfm ng/jointtraining.cfm

Is it bigger than a bread box?

Multi-drug Resistant Organisms: Organizing Your Interventions

Delivery of Healthcare Home Acute Care ASC LTC LTACH How do you maintain quality and continuity of care across settings?

Organizing - Surveillance What is important in your facility? Are certain residents high risk? Documentation new residents status? – Infection or colonization with MDRO Start small and keep it simple Trends over time – run chart Make data available to all staff

Organizing – Bundles, Checklists A “bundle” is a collection of processes (items) needed to effectively care for patients The idea is to bundle together a small number of elements essential to improving clinical outcomes A bundle should be relatively small and straightforward − a set of three to five practices or precautionary steps is ideal A bundle is scored as all or none, no partial credit Pilot’s check list – manage complexity Institute for Healthcare Improvement

Clostridium Difficile Discovered in 1935 by Hall & O’Toole. Ubiquitous anaerobic gram-positive spore forming bacillus. Causes 20-30% of all antibiotic associated diarrhea Named “difficult clostridium” due to its resistance in isolation and growth. In 1978 C. difficile produced toxin was found in patients with antibiotic- associated pseudomembranous colitis. Not all strains toxigenic. Normally found in ~ 3% adults and 15-60% children < 1 yo, 10% to 20% of hospitalized patients Rate and severity of C. difficile-associated diarrhea (CDI) increasing New strain of C.difficile with increased resistance and virulence identified. LaMont, 2006

Prevention Strategies: Core Contact Precautions for duration of diarrhea Hand hygiene in compliance with CDC/WHO Cleaning and disinfection of equipment and environment Laboratory-based alert system for immediate notification of positive test results Educate about CDI: HCP, housekeeping, administration, patients, families Dubberke et al. Infect Control Hosp Epidemiol 2008;29:S81-92.

Prevention Strategies: Supplemental Extend use of Contact Precautions beyond duration of diarrhea (e.g., 48 hours)* Presumptive isolation for symptomatic patients pending confirmation of CDI Evaluate and optimize testing for CDI Implement soap and water for hand hygiene before exiting room of a patient with CDI Implement universal glove use on units with high CDI rates* Use sodium hypochlorite (bleach) – containing agents for environmental cleaning Implement an antimicrobial stewardship program * Not included in CDC/HICPAC 2007 Guideline for Isolation Precautions

Rationale for considering extending isolation beyond duration of diarrhea Bobulsky et al. Clin Infect Dis 2008;46:

Outline of a C. difficile “Bundle of Bundles” Prompt identification and isolation of cases – at first suspicion Laboratory testing Hand hygiene Environmental cleaning Antimicrobial stewardship Surveillance Visitors ???

LTCF and Reporting HAI Texas Healthcare-associated Infection and Preventable Adverse Event Reporting

NHSN (National Healthcare Safety Network) see packet material Voluntary, secure, internet-based surveillance system Integrates patient and healthcare personnel safety surveillance systems Managed by the Division of Healthcare Quality Promotion (DHQP) at CDC. Open to all types of healthcare facilities in the United States, including acute care hospitals, long term acute care hospitals, psychiatric hospitals, rehabilitation hospitals, outpatient dialysis centers, ambulatory surgery centers, and long term care facilities.

31 View reports & comment CMS HAI Reporting

Significance of Multi-Drug Resistant Microorganisms

MDRO definition MDROs are defined as microorganisms, predominantly bacteria, that are resistant to one or more classes of antimicrobial agents Although the names of certain MDROs describe resistance to only one agent (e.g., MRSA, VISA/VRSA, PRSP) extended spectrum beta-lactamases (ESBLs) and others that are resistant to multiple classes of antimicrobial agents, are of particular concern In addition to Escherichia coli and Klebsiella pneumoniae intrinsically resistant to the broadest-spectrum antimicrobial agents – Fairly common to the Gram negative bacteria – Acinetobacter baumannii resistant to all antimicrobial agents, or all except imipenem – Stenotrophomonas maltophilia - Burkholderia cepacia -Ralstonia pickettii

CRE invades U.S. health care facilities

35 Spread of Carbapenemase Producers

Carbapenem-resistant Enterobacteriaceae (CRE)  Common cause of HAIs  Found in both acute care hospitals and long-term care settings  Since 2004, reports of CRE cases from LTACH and LTCF  Similar to the spread of other MDROs  Movement of colonized patients across the continuum of care contributes to regional transmission  Supported by mathematical modeling Urban C et al. Clin Infect Dis 2008;46:e Endimiani A et al. J Antimicrob Chemother 2009;64: Smith DL et al. PNAS 2004;101:

Inter-Facility Transmission of MDROs (Including CRE) Munoz-Price SL. Clin Infect Dis 2009;49:

Healthcare Community KPC outbreak, Chicago 2008 Clin Infect Dis 2011;53:

Urine Culture Result 39

Important Concepts for MDRO Transmission Once introduced, transmission and persistence depend on: – availability of vulnerable patients – selective pressure exerted by AMR use – >potential for transmission with > numbers of colonized or infected patients ("colonization pressure") – impact of implementation and adherence to prevention efforts.

Important Concepts for MDRO Transmission 2 Patients vulnerable to colonization and infection include – severe disease – compromised host defenses from underlying medical conditions – recent surgery – or indwelling medical devices (e.g., urinary catheters, central lines, or endotracheal tubes – Hospitalized- esp. in ICU

/threat-report-2013/pdf/ar-threats pdf

94% 6%

Epidemiologically Important  Common cause of infection  Multidrug-resistant, limited treatment options  Capable of transferring resistance  High mortality rates for invasive infections  Potential to spread out of healthcare settings

What Can Healthcare Professionals Do? Know if patients in your facility have CRE. Request immediate alerts when the lab identifies CRE. Alert the receiving facility when a patient with CRE transfers out, and find out when a patient with CRE transfers into your facility. Protect your patients from CRE. Follow contact precautions and hand hygiene recommendations when treating patients with CRE.

What Can Healthcare Professionals Do? Dedicate rooms, staff, and equipment to patients with CRE. Prescribe antibiotics wisely (Get Smart for Healthcare). Remove temporary medical devices such as catheters and ventilators from patients as soon as possible. Report cases promptly Communicate!

See Handout

Disclosure of PHI

Texas MDRO Reporting  CDC Tool Kit (  CRE E. coli, Klebsiella species, MDR Acinetobacter Voluntary 2013 Mandatory likely 2 nd Q DSHS lab capacity  All sites to be reported  No isolate submission mandated  NHSN case definitions

Surveillance Definitions Facilities/Regions should have an awareness of the prevalence of CRE in their Facility and Community Focus on Klebsiella species, E. coli and MDR Acinetobacter CDC CRE surveillance definition (2012 breakpoints) Nonsusceptible to one of the carbapenems: doripenem, meropenem, or imipenem AND Resistant to all 3 rd generation cephalosporins tested (Some Enterobacteriaceae are intrinsically resistant to imipenem e.g. Morganella, Providencia, Proteus)

The Burning Platform

Why We Need to Improve Antibiotic Use Antibiotics are often over- or misused in hospitals Antibiotic misuse adversely impacts patients and society by driving the development of resistance. Antibiotics are the only drugs where use in one patient can impact the effectiveness in another. Optimizing antibiotic use improves patient outcomes and reduces wasting these vital drugs Improving antibiotic use is a public health imperative

So What Can We Do? Given the increasing numbers of MDROs and the sparse number of new antibiotics, we need to “get back to basics”. Give fewer antibiotics (“de-escalate” from broad spectrum combinations) and treat for fewer total days. Don’t treat viral illnesses with antibiotics. Don’t treat colonization –wounds, trach tube, Foley. Remove foreign bodies e.g. CVPs, Foleys if possible Use maximum barrier precautions HAND HYGIENE BETWEEN ALL PATIENTS

Optimize selection, dose and duration of Rx for improved patient outcomes Prevent or slow the emergence of antimicrobial resistance Reduce adverse drug events including secondary infection (e.g. C. difficile infection) Reduce morbidity and mortality Reduce length of stay Reduce health care expenditures Antimicrobial Stewardship Goals MacDougall CM and Polk RE. Clin Micro Rev 2005;18(4): Ohl CA. J. Hosp Med 2011 Jan;6 Suppl 1:S4-15. Dellit TH, et. al. Clin Infect Dis. 2007;44:

Outbreak Reporting  Several Texas laws (Health & Safety Code, Chapters 81, 84, and 87) require specific information regarding notifiable conditions be provided to the Texas Department of State Health Services (DSHS). Health care providers, hospitals, laboratories, schools, and others are required to report patients who are suspected of having a notifiable condition (Chapter 97, Title 25, Texas Administrative Code ). Health & Safety Code, Chapters 81, 84, and 87Chapter 97, Title 25, Texas Administrative Code

Outbreak Reporting

Conclusions – MDRO are associated with significantly increased hospital costs – Investing in state-of-the-art, aggressive infection prevention and antibiotic stewardship programs can result in considerable cost savings – Healthcare Executives should request careful accounting regarding the economic impact of both MDRO and institutional control programs.

DSHS Regulations t.ViewTAC?tac_view=4&ti=25&pt=1&ch=133 t.ViewTAC?tac_view=4&ti=25&pt=1&ch=133 Every Facility type has their own set of rules.

DADS Regulations

Resources ations/handbooks/index.html#handbooks ations/handbooks/index.html#handbooks cp/infectioncontrol/index.html cp/infectioncontrol/index.html tings.html tings.html

Resources continued (McGeer Surv.) (SHEA LTC guide) care/index.html care/index.html